Portal de investigación
ESTUDIO DE SEGURIDAD Y TOLERABILIDAD A LARGO PLAZO DE LA ADMINISTRACIÓN ABIERTA DE AMIKACINA LIPOSOMAL PARA INHALACIÓN (ARIKACE) EN PACIENTES CON FIBROSIS QUÍSTICA CON INFECCIÓN CRÓNICA POR PSEUDOMONAS AERUGINOSA.
Datos básicos
- Protocolo:
- TR02-110
- EUDRACT:
- 2011-000443-24
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2012
- Año de finalización:
- 2015
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[Disseminated non-tuberculous mycobacterial infection in a patient with hyper-IgE syndrome].
Romero Rubio MT; (...); Santos Serrano L
Letter. 10.1016/j.anpedi.2013.01.017. 2013
Absceso orbitario tras anestesia peribulbar en mucocele frontoetmoidal.
Pardo-López D; (...); Diaz-Llopis M
Abstract of Published Item. 10.1016/j.oftal.2013.02.009. 2014
Burden of serious fungal infections in Spain
Rodriguez-Tudela JL; (...); University of Manchester in association with the LIFE program
Article. 10.1016/j.cmi.2014.07.013. 2015
Component-resolved diagnosis: Performance of specific IgE to Alternaria compared to Alt a 1
Nieto M; (...); Mazon A
Letter. 10.1111/pai.12305. 2014
Cystic fibrosis in adult age
Lerin, M; (...); Alvarez-Sala, R
Article. 10.1016/j.rce.2014.05.001. 2014
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
Garnacho-Montero J; (...); Barberán J
Article. 2013
Erratum to "Practical guidelines: lung transplantation in patients with cystic fibrosis".
Hirche TO; (...); ECORN-CF Study Group
Article. 10.1155/2015/698460. 2015
Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study
Sarmiento, E; (...); Carbone, J
Article. 10.1016/j.healun.2016.10.004. 2017
Functional Outcomes After Lung Transplant in Chronic Obstructive Pulmonary Disease
Navarro, JC; (...); Alarcon, JP
Article. 10.1016/j.arbres.2014.06.012. 2015
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke
Puig, J; (...); Castellanos, M
Article. 10.1371/journal.pone.0188238. 2017
Hyperkalemia in heart failure patients: current challenges and future prospects
Lopez-Vilella, R; (...); Almenar-Bonet, L
Review. 10.2147/RRCC.S75680. 2016
Management of pulmonary exacerbations in cystic fibrosis: still an unmet medical need in clinical practice
Justicia JL; (...); Máiz L
Review. 10.1586/17476348.2015.1016504. 2015
Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.
Awatade, NT; (...); Amaral, MD
Article. 10.1016/j.ebiom.2014.12.005. 2015
Nocardia farcinica lung infection in a patient with cystic fibrosis and a lung transplant.
Chacón CF; (...); Ansotegui E
Article. 10.1016/j.redar.2014.04.010. 2015
Paediatric patients with a tracheostomy: a multicentre epidemiological study.
Pérez-Ruiz E; (...); García E
Article. 10.1183/09031936.00164611. 2012
Practical guidelines: lung transplantation in patients with cystic fibrosis.
Hirche TO; (...); ECORN-CF Study Group
Article. 10.1155/2014/621342. 2014
Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries
Quittner AL; (...); Barker D
Article. 10.1136/thoraxjnl-2014-205983. 2014
Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant.
Monforte V; (...); Román A
Article. 10.1016/j.healun.2012.11.013. 2013
Recommendations on the use of everolimus in lung transplantation.
de Pablo A; (...); Zurbano F
Article. 10.1016/j.trre.2012.11.001. 2013
Safety of anidulafungin in solid organ transplant recipients.
Aguado JM; (...); Montejo M
Article. 10.1002/lt.23410. 2012
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Cantón R; (...); Solé A
Article. 10.1016/j.arbres.2014.09.021. 2015
Spanish Heart Transplant Registry. 29th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure
Gonzalez-Vilchez, F; (...); Representation Equipos Espanoles T
Article. 10.1016/j.recesp.2018.07.020. 2018
Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)
Gonzalez-Vilchez, F; (...); Abella-Anton, R
Article. 10.1016/j.rec.2019.09.005. 2019
Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology.
González-Vilchez F; (...); Groba Marco MDV
Article. 10.1016/j.rec.2020.06.035. 2020
Thrombotic microangiopathy associated with tacrolimus in lung transplantation.
Reig Mezquida JP; (...); Pastor Guillem J
Article. 10.1016/j.arbres.2014.07.004. 2015
Trasplante pulmonar en la linfangioleiomiomatosis esporádica. Estudio de 7 casos.
Ansótegui Barrera E; (...); Padilla Alarcón J
Abstract of Published Item. 10.1016/j.medcli.2013.05.036. 2013